Health
Heart Transplant ‘Liquid Biopsy’; PCSK9 CRISPR; More SGLT2 Drugs Try FDA in HF – MedPage Today
Recent developments of interest in cardiovascular medicine
A blood test showed promise as a “liquid biopsy” for detection of acute heart transplant rejection. (Circulation)
Early efforts to use CRISPR to edit PCSK9 genes in severe heterozygous familial hypercholesterolemia are moving forward. (Endpoints News)
In a study of 145 student athletes with no more than moderate COVID-19 symptoms, cardiac MRI a median 15 days after the positive test was consistent with myocarditis in two (1.4%). (JAMA Cardiology)
Each extra serving of fried foods per week was linked…
-
Noosa News23 hours agoDesign and construction integrity rewarded with national award
-
Noosa News17 hours agoConfusion over licensing and access to hunting grounds under WA’s strict gun laws
-
General7 hours agoChina and Philippines trade blame over latest South China Sea clash
-
General14 hours agoCalls for government to ‘get on with’ CSIRO Ginninderra Experiment Station land sale after three-year delay